Evaluation of the efficacy, safety and glycaemic effects of evolocumab ( AMG 145) in hypercholesterolaemic patients stratified by glycaemic status and metabolic syndrome
Year: 2016
Type: article
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.12788
Institutions: University of Cape Town, Jacksonville Center for Clinical Research, Sterling Research Group, Amgen (United States), Gilead Sciences (United States), Ionis Pharmaceuticals (United States), Amgen (United Kingdom), Houston Methodist, Baylor College of Medicine, University of Oxford, Oxford Centre for Diabetes, Endocrinology and Metabolism
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2522643247
